作者：
Reardon,D.A. [1]
;
Vredenburgh,J.J. [2]
;
Desjardins,A. [3]
;
Peters,K.B. [4]
;
Sathornsumetee,S. [5]
;
Threatt,S. [6]
;
Sampson,J.H. [7]
;
HerndonII,J.E. [8]
;
Coan,A. ;
McSherry,F. ;
Rich,J.N. ;
McLendon,R.E. ;
Zhang,S. ;
Friedman,H.S.
作者单位：
Departments of Cancer Center Biostatistics, Preston Robert Tisch Brain Tumor Center, Duke
[1]
Departments of Surgery, Preston Robert Tisch Brain Tumor Center, Duke University Medical Center
[2]
Department of Stem Cell Biology and Regenerative Medicine, Cleveland Clinic, Cleveland, OH, United
[3]
Department of Clinical Pharmacology and Pharmacometrics, Bristol-Myers Squibb, Princeton, NJ
[4]
Departments of Pathology, Preston Robert Tisch Brain Tumor Center, Duke University Medical Center
[5]
Departments of Medicine, Preston Robert Tisch Brain Tumor Center, Duke University Medical Center
[6]
Department of Medicine (Neurology), Faculty of Medicine at Siriraj Hospital, Mahidol University
[7]
Center for Neuro-Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, SW-430, Boston, MA
[8]
发布时间
2013-11-20
换一批
